UArizona Researchers Develop Ultra-Thin ‘Computer on the Bone’

osseosurface electronic device applied to a synthetic bone Osseosurface electronic devices, which attach directly to the bone, could one day help physicians monitor bone health. It's show here applied to a synthetic bone in the Gutruf Lab at the University of Arizona. Image Courtesy of Gutruf Lab

osseosurface electronic device applied to a synthetic bone Osseosurface electronic devices, which attach directly to the bone, could one day help physicians monitor bone health. It’s show here applied to a synthetic bone in the Gutruf Lab at the University of Arizona. Image Courtesy of Gutruf Lab

Engineers and physicians teamed up to develop a wireless device to monitor and protect bone health.Continue reading

Life Science Leaders Weigh In On Build Back Better Provisions

On Friday, November 19, 2021, the U.S. House of Representatives passed the Build Back Better bill on a 220-213 vote.  The bill now moves to the Senate for further review and action. Valued at close to $2 trillion, the bill includes  a potpourri of  Democratic social spending priorities that includes free preschool for 3 and 4 year old children, initiatives to fight climate change and affordable housing programs. The bill also includes increases to  Pell grants for college tuition, expands family leave, and provides new hearing benefit for seniors.   It also incudes “pay fors” including   increases corporate taxes, funds additional resources for IRS enforcement, AND implements price controls on certain medicines.  Investors and life science companies of all sizes have expressed serious concerns that if the latter provisions pass the Senate and are implemented the impact on future health innovation could be devastating. Continue reading

Coronavirus (COVID-19) Update: FDA Expands Eligibility for COVID-19 Vaccine Boosters

November 19, 2021: Today, the U.S. Food and Drug Administration amended the emergency use authorizations (EUA) for both the Moderna and Pfizer-BioNTech COVID-19 vaccines authorizing use of a single booster dose for all individuals 18 years of age and older after completion of primary vaccination with any FDA-authorized or approved COVID-19 vaccine. The Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices will meet later today to discuss further clinical recommendations.Continue reading